LY294002, an inhibitor of phosphatidylinositol-3-kinase, causes preferential induction of apoptosis in human multidrug resistant cells

被引:19
|
作者
Nicholson, KM [1 ]
Quinn, DM [1 ]
Kellett, GL [1 ]
Warr, JR [1 ]
机构
[1] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England
关键词
LY294002; multidrug resistance; apoptosis;
D O I
10.1016/S0304-3835(02)00615-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Protein kinase B (PKB), a kinase downstream of phosphatidylinositol 3-kinase (PI3-kinase) provides anti-apoptotic and survival signals via phosphorylation of various targets. Inhibiting PI3-kinase with a 12 h exposure to 10 muM LY294002 induces levels of apoptosis of 30.39 +/- 1.53% in the KB-V1 multidrug resistant (MDR) cell line compared to 4.54 +/- 1.00% in drug sensitive KB-3-1 cells (P < 0.001). This occurred in conjunction with a preferential reduction in activated PKB in MDR cells. These results suggest the PI3-kinase/PKB signalling pathway is important for the survival of MDR cells and inhibition of this pathway results in the selective induction of apoptosis in MDR cells. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 50 条
  • [21] Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells
    Masao Fujiwara
    Kunihiko Izuishi
    Takanori Sano
    Mohammad Akram Hossain
    Shoji Kimura
    Tsutomu Masaki
    Yasuyuki Suzuki
    Journal of Experimental & Clinical Cancer Research, 27
  • [22] Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells
    Fujiwara, Masao
    Izuishi, Kunihiko
    Sano, Takanori
    Hossain, Mohammad Akram
    Kimura, Shoji
    Masaki, Tsutomu
    Suzuki, Yasuyuki
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2008, 27 (1)
  • [23] Preferential induction of apoptosis in multidrug resistant cells by PDMP, an inhibitor of ceramide metabolism
    Nicholson, KM
    Quinn, DM
    Kellett, GL
    Warr, JR
    BRITISH JOURNAL OF CANCER, 1998, 78 : 34 - 34
  • [24] Induction of insulin resistance by phosphatidylinositol-3-kinase inhibitor in porcine granulosa cells
    Yan, Miaoe
    Wang, Jing
    Wu, Xiaoke
    Hou, Lihui
    Kuang, Haixue
    Wang, Yongyan
    FERTILITY AND STERILITY, 2009, 92 (06) : 2119 - 2121
  • [25] NMDA neuroprotection against a phosphatidylinositol-3 kinase inhibitor, LY294002 by NR2B-mediated suppression of glycogen synthase kinase-3β-induced apoptosis
    Habas, A
    Kharebava, G
    Szatmari, E
    Hetman, M
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 (02) : 335 - 348
  • [26] LY294002 and Metformin Cooperatively Enhance the Inhibition of Growth and the Induction of Apoptosis of Ovarian Cancer Cells
    Li, Cuilan
    Liu, Vincent Wing Sun
    Chan, David Wai
    Yao, Kwok Ming
    Ngan, Hextan Yuen Sheung
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (01) : 15 - 22
  • [27] The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes
    Blommaart, EFC
    Krause, U
    Schellens, JPM
    VreelingSindelarova, H
    Meijer, AJ
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2): : 240 - 246
  • [28] The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains
    Dittmann, Antje
    Werner, Thilo
    Chung, Chun-Wa
    Savitski, Mikhail M.
    Savitski, Maria Faelth
    Grandi, Paola
    Hopf, Carsten
    Lindon, Matthew
    Neubauer, Gitte
    Prinjha, Rabinder K.
    Bantscheff, Marcus
    Drewes, Gerard
    ACS CHEMICAL BIOLOGY, 2014, 9 (02) : 495 - 502
  • [29] PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues
    Abbott, BM
    Thompson, PE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (11) : 2847 - 2851
  • [30] The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3′-kinase, in human colon cancer cells
    Semba, S
    Itoh, N
    Ito, M
    Harada, M
    Yamakawa, M
    CLINICAL CANCER RESEARCH, 2002, 8 (06) : 1957 - 1963